Funder: National Institutes of Health
Due Dates: September 3, 2026 (Estimated, Forecasted)
Funding Amounts: Estimated total program funding: $8,000,000; ~7 awards expected
Summary: Supports bold, groundbreaking, and exceptionally innovative biomedical research with potential for transformative impact; open to a broad range of applicants.
Key Information: No preliminary data required; clinical trials are optional; forecasted opportunity—dates and details may change.